4dmedical Ltd. · ASX:4DX
4dmedical — Shareholder Meeting (June 2023)
15 slides from 4dmedical's shareholder meeting presentation, Jun 14, 2023
Slide 1: ASX announcement: Presentation and CEO's address to the 2023 EGM
ASX announcement ASX:4DX Presentation and CEO's address to the 2023 Extraordinary General Meeting 14 June 2023 4DMedical Limited (ASX:4DX, “4DMedical” or the “Company”) attaches the following materials to be presented at the Extraordinary General Meeting of Shareholders to be held today at 11.30am A
Slide 2: Managing Director and CEO's address
4DMedical Limited Extraordinary General Meeting Managing Director and CEO’s address 11.30AM, Wednesday 14 June 2023 Good morning ladies and gentlemen, I am excited to be here with you today following our recent successes in capital raising, resulting in a significant expression of confidence in 4DMe
Slide 3: The future of lung health – Extraordinary General Meeting
For personal use only The future of lung health 4DMedical Limited (ASX:4DX) Extraordinary General Meeting 14 June 2023 11:30am 4DMedical Limited ABN 31 161 684 831
Slide 4: Disclaimer
Disclaimer This presentation has been prepared by 4DMedical Limited (ACN 161 684 831) (Company or 4DMedical). This presentation contains summary information about the Company, its subsidiaries and the entities, businesses and assets they own and operate (Group) and their activities current as of 14
Slide 5: 2023 EGM agenda
2023 EGM agenda For personal use only 1. Opening & introductions 2. CEO address 3. Procedural matters 4. Formal business 5. Closing remarks 4DMedical Limited (ASX:4DX) – EGM Presentation | June 2023 3
Slide 6: Chairman's introduction
For personal use only Chairman’s introduction BRUCE RATHIE Non-Executive Chairman Experienced lawyer, investment banker and company director.
Slide 7: Board of directors
Board of directors The Board has the right mix of medical and commercial sector experience Key Advisors Dr SAM HUPERT MBBS For personal use only Advisory Board Member Co-founder and Chief Executive Officer of Pro Medicus Ltd (PME.ASX) which develops and markets health imaging software primarily for
Slide 8: Chief Executive Officer
For personal use only Chief Executive Officer Dr ANDREAS FOURAS PhD Managing Director Award-winning aerospace engineer and innovator responsible for the conception and development of 4DMedical’s core technologies.
Slide 9: Procedural matters
For personal use only Procedural matters
Slide 10: Formal business
For personal use only Formal business
Slide 11: Items of Business
Items of Business For personal use only Resolution 1: Ratification of issue of Shares under the Offers. Resolution 2: Approval of proposed issue of New Options under the Offers. 4DMedical Limited (ASX:4DX) – EGM Presentation | June 2023 9
Slide 12: Formal business: Item 1 Ratification of issue of Shares
Formal business Item 1. Ratification of issue of Shares under the Offers. For personal use only To consider, and if thought fit, to pass, the following as an ordinary resolution: “That, in accordance with Listing Rule 7.4 and for all other purposes, Shareholders ratify the issue by the Company of Sh
Slide 13: Formal business: Item 2 Approval of New Options
Formal business Item 2. Approval of proposed issue of New Options under the Offers. For personal use only To consider, and if thought fit, to pass, the following as an ordinary resolution: “That, in accordance with Listing Rule 7.1 and for all other purposes, Shareholders approve the proposed issue
Slide 14: Poll
For personal use only Poll
Slide 15: The Future of Lung Health
For personal use only The Future of Lung Health 4DMedical Limited (4DX) Corporate Administration Media Enquiries CFO Company Secretary TCN Simon Glover Naomi Lawrie Julia Maguire sglover@4dmedical.com companysecretary@4dmedical.com julia@thecapitalnetwork.com.au